awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38598893-E973BB87-B6F3-4F54-A8E1-BDDC21CBFEF0
Q38598893-E973BB87-B6F3-4F54-A8E1-BDDC21CBFEF0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38598893-E973BB87-B6F3-4F54-A8E1-BDDC21CBFEF0
Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy
P2860
Q38598893-E973BB87-B6F3-4F54-A8E1-BDDC21CBFEF0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38598893-E973BB87-B6F3-4F54-A8E1-BDDC21CBFEF0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d6597af4a477207f5bd747494cad14e15807d6f7
P2860
Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer.